Cullinan Therapeutics, Inc.
CGEM
Rank in Stocks
#10257
Cullinan Therapeutics, Inc. operates as a biopharmaceutical firm actively... Cullinan Therapeutics, Inc. operates as a biopharmaceutical firm actively advancing its therapeutic candidates through clinical trials. This company is focused on developing innovative treatments primarily for cancer, including those that leverage the immune system (immuno-oncology). Its current roster of investigational drugs comprises CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. Patrick A. Baeuerle founded the organization on September 15, 2016, and it is presently headquartered in Cambridge, Massachusetts.
Share Price
$11.73
Last synced: 2026-11-09
Market Cap
$720.90M
Change (1 day)
3.71%
Change (1 year)
50.38%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cullinan Therapeutics, Inc. (CGEM)
Category
Healthcare
Operating Margin for Cullinan Therapeutics, Inc. (CGEM)
Operating Margin as of November 2026 TTM: 0.00%
According to Cullinan Therapeutics, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Cullinan Therapeutics, Inc. from 2018 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | -100.00% |
| 2021 | -358.73% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Cullinan Therapeutics, Inc.'s operating margin
What was Cullinan Therapeutics, Inc.'s operating margin in 2025?
In 2025, Cullinan Therapeutics, Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has Cullinan Therapeutics, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Cullinan Therapeutics, Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2021 (-358.73%).
How does Cullinan Therapeutics, Inc.'s operating margin compare with similar companies?
Cullinan Therapeutics, Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.